LMR Partners LLP

Q1 2025 13F-HR Holdings

Location
London, X0
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
1,326
Total value ($000)
$10,691,344
Net value change ($000)
-1,199,805 (-10.1%)
New positions
303
Sold out positions
207
Turnover %
57.6%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/14/2025 Next filing: 8/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. 113,182 16571.3%
ROP 48,551 NEW
INTC 46,752 1728.4%
NTNX 43,049 NEW
STX 41,789 503.8%
CHX 37,024 357.9%
NOK 35,769 NEW
H&E Equipment Services, Inc. 32,793 NEW
ADSK 31,417 NEW
YUMC 31,074 3052.5%
Top Reduces (Value $000, Stocks/ETFs)
SPY -467,480 -99.2%
Endeavor Group Holdings, Inc. -203,648 -100.0%
NVDA -56,200 -57.6%
BA -43,115 -89.7%
TER -38,871 -94.0%
GLW -38,732 -67.9%
FLEX -36,471 -100.0%
VRTX -34,919 -92.4%
INFY -32,853 -100.0%
FYBR -28,453 -40.7%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 5,715,086 (53.5% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type